<p>BERKELEY HEIGHTS, N.J., Nov. 28, 2023 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company
USD/CHF remains likely to fall. Estimated pivot point is at the level of 0.9530. Main scenario: consider short positions from corrections below the level of 0.9530 with the target in 0.9170 – 0.9050.
Leave a Comment